chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 33.0
Sex: M
Vaccine: FLU3
Symptoms: Rash erythematous
Clinical narrative: THE PT RECIEVED A SINGLE DOSE OF FLUZONE FROM A MULTIDOSE VIAL USING THE NEW PHARMAJET NEEDLE-FREE MACHINE ON FRIDAY SEPTEMBER 9, 2011 AND BY SATURDAY HIS ARM HAD A LARGE HOT RED RASH FROM ABOVE THE SHOULDER TO ABOUT 7 INCHES DOWN AND IT WAS PAINFUL AND THE INJECTION SITE HAD A ROUND HARD LUMP ABOUT A CENTIMETER IN DIAMETER.  THE RASH WAS GONE BY MONDAY BUT THE HARD LUMP WAS STILL PRESENT AT THE INJECTION SITE AND THE AREA WAS STILL HOT.
Age: 21.0
Sex: F
Vaccine: FLU3
Symptoms: Injection site induration, Injection site mass, Injection site pain, Injection site reaction, Injection site warmth
Clinical narrative: THE PT RECIEVED A SINGLE DOSE OF FLUZONE FROM A MULTIDOSE VIAL USING THE NEW PHARMAJET NEEDLE-FREE MACHINE ON FRIDAY SEPTEMBER 9, 2011 AND BY SATURDAY HER ARM HAD A LARGE HOT RED RASH FROM ABOVE THE SHOULDER TO ABOUT 7 INCHES DOWN AND IT WAS PAINFUL AND THE INJECTION SITE HAD A ROUND HARD LUMP ABOUT A CENTIMETER IN DIAMETER.  THE RASH WAS GONE BY MONDAY BUT THE HARD LUMP WAS STILL PRESENT AT THE INJECTION SITE AND THE AREA WAS STILL HOT.
Age: 21.0
Sex: F
Vaccine: FLU3
Symptoms: Rash erythematous
Clinical narrative: THE PT RECIEVED A SINGLE DOSE OF FLUZONE FROM A MULTIDOSE VIAL USING THE NEW PHARMAJET NEEDLE-FREE MACHINE ON FRIDAY SEPTEMBER 9, 2011 AND BY SATURDAY HER ARM HAD A LARGE HOT RED RASH FROM ABOVE THE SHOULDER TO ABOUT 7 INCHES DOWN AND IT WAS PAINFUL AND THE INJECTION SITE HAD A ROUND HARD LUMP ABOUT A CENTIMETER IN DIAMETER.  THE RASH WAS GONE BY MONDAY BUT THE HARD LUMP WAS STILL PRESENT AT THE INJECTION SITE AND THE AREA WAS STILL HOT.
Age: 58.0
Sex: M
Vaccine: FLU3
Symptoms: Erythema, Pruritus, Urticaria
Clinical narrative: ITCHY, RED HIVES UNDER LEFT ARM AND ACROSS THE UPPER CHEST AREA
Age: 45.0
Sex: F
Vaccine: FLU3
Symptoms: Asthenia, Dizziness, Dyspnoea, Feeling hot, Oropharyngeal pain
Clinical narrative: After injection I felt warm then weak then dizzy. Approximately one hour after that my tongue began to swell and tingle. I became tachycardic, sore throat, some SOB & tongue cont to have some swelling & tingling. Took 2 MOTRIN 400 mg- BENADRYL Albuterol inhaler.
Age: 45.0
Sex: F
Vaccine: FLU3
Symptoms: Paraesthesia oral, Swollen tongue, Tachycardia
Clinical narrative: After injection I felt warm then weak then dizzy. Approximately one hour after that my tongue began to swell and tingle. I became tachycardic, sore throat, some SOB & tongue cont to have some swelling & tingling. Took 2 MOTRIN 400 mg- BENADRYL Albuterol inhaler.
Age: 33.0
Sex: F
Vaccine: FLU3
Symptoms: Cough, Dyspnoea
Clinical narrative: After patient left started coughing & had trouble breathing. This started about 30 minutes after the vaccine. She went to ER & received steroid shot. She saw her allergy doctor next day and was feeling little better.
Age: 18.0
Sex: F
Vaccine: HEPAB, MMR, HEPAB, MMR
Symptoms: Convulsion, Fall, Hypersensitivity, Immediate post-injection reaction, Presyncope
Clinical narrative: This case was reported by a healthcare professional and described the occurrence of syncope in a 18-year-old female subject who was vaccinated with TWINRIX (GlaxoSmithKline), MMR II (Merck). Concurrent medical conditions included fainting. Concurrent medications included Triamcinolone and FLONASE. On 7 September 2011 at 11:15 the subject received 1st dose of TWINRIX at 0.5 ml in the left arm while in a seated position. On 7 September 2011 the subject also received 1st dose of MMR II (Merck). On 7 September 2011, immediately after vaccination with TWINRIX the subject experienced syncope and fell. She had also been injected with MMR II (Merck) and experienced a seizure immediately following. Fainting was also reported. The healthcare professional considered the events were disabling, life threatening and clinically significant (or requiring intervention). The subject was taken to the emergency room where she was discharged the same day. A systemic shot reaction was reported. The subject was told by cardiology that she had experienced a vasovagal response. Syncope, seizure, fainting and falling were all reported to have resolved. Attribution of these events to vaccination with TWINRIX was not reported.
Age: 18.0
Sex: F
Vaccine: HEPAB, MMR, HEPAB, MMR
Symptoms: Syncope
Clinical narrative: This case was reported by a healthcare professional and described the occurrence of syncope in a 18-year-old female subject who was vaccinated with TWINRIX (GlaxoSmithKline), MMR II (Merck). Concurrent medical conditions included fainting. Concurrent medications included Triamcinolone and FLONASE. On 7 September 2011 at 11:15 the subject received 1st dose of TWINRIX at 0.5 ml in the left arm while in a seated position. On 7 September 2011 the subject also received 1st dose of MMR II (Merck). On 7 September 2011, immediately after vaccination with TWINRIX the subject experienced syncope and fell. She had also been injected with MMR II (Merck) and experienced a seizure immediately following. Fainting was also reported. The healthcare professional considered the events were disabling, life threatening and clinically significant (or requiring intervention). The subject was taken to the emergency room where she was discharged the same day. A systemic shot reaction was reported. The subject was told by cardiology that she had experienced a vasovagal response. Syncope, seizure, fainting and falling were all reported to have resolved. Attribution of these events to vaccination with TWINRIX was not reported.
Age: 18.0
Sex: F
Vaccine: HEPAB, MMR, HEPAB, MMR
Symptoms: Condition aggravated, Convulsion, Fall, Immediate post-injection reaction, Immunisation reaction
Clinical narrative: This case was reported by a healthcare professional and described the occurrence of syncope in a 18-year-old female subject who was vaccinated with TWINRIX (GlaxoSmithKline), MMR II (Merck). Concurrent medical conditions included fainting. Concurrent medications included Triamcinolone and FLONASE. On 7 September 2011 at 11:15 the subject received 1st dose of TWINRIX at 0.5 ml in the left arm while in a seated position. On 7 September 2011 the subject also received 1st dose of MMR II (Merck). On 7 September 2011, immediately after vaccination with TWINRIX the subject experienced syncope and fell. She had also been injected with MMR II (Merck) and experienced a seizure immediately following. Fainting was also reported. The healthcare professional considered the events were disabling, life threatening and clinically significant (or requiring intervention). The subject was taken to the emergency room where she was discharged the same day. A systemic shot reaction was reported. The subject was told by cardiology that she had experienced a vasovagal response. Syncope, seizure, fainting and falling were all reported to have resolved. Attribution of these events to vaccination with TWINRIX was not reported.
Age: 18.0
Sex: F
Vaccine: HEPAB, MMR, HEPAB, MMR
Symptoms: Presyncope, Syncope
Clinical narrative: This case was reported by a healthcare professional and described the occurrence of syncope in a 18-year-old female subject who was vaccinated with TWINRIX (GlaxoSmithKline), MMR II (Merck). Concurrent medical conditions included fainting. Concurrent medications included Triamcinolone and FLONASE. On 7 September 2011 at 11:15 the subject received 1st dose of TWINRIX at 0.5 ml in the left arm while in a seated position. On 7 September 2011 the subject also received 1st dose of MMR II (Merck). On 7 September 2011, immediately after vaccination with TWINRIX the subject experienced syncope and fell. She had also been injected with MMR II (Merck) and experienced a seizure immediately following. Fainting was also reported. The healthcare professional considered the events were disabling, life threatening and clinically significant (or requiring intervention). The subject was taken to the emergency room where she was discharged the same day. A systemic shot reaction was reported. The subject was told by cardiology that she had experienced a vasovagal response. Syncope, seizure, fainting and falling were all reported to have resolved. Attribution of these events to vaccination with TWINRIX was not reported.
Age: 85.0
Sex: F
Vaccine: VARZOS
Symptoms: Erythema, Injection site pain, Pruritus, Rash
Clinical narrative: Patient received vaccine the morning of 9/6. In the afternoon the redness and itching began, and the redness slightly disappeared the morning of 9/9. The redness was as big as her hand and the itching went from her elbow to her armpit. The patient reported using Hydrocortisone cream for 24 hours but then stopped. Patient stated that it looks like a rash and is painful to the touch just below the injection site. Educated patient to take Tylenol PRN for pain and she had some loratidine. Told patient she could take loratidine now but Benadryl would work the best. Recommended that she take one before bedtime. Patient reported having shingles in the past and stated that it does not look like shingles yet but looks like it might be turning into the shingles. Told patient that if it starts to look like the shingles again then to call her MD. Followed up with patient on 9/12 and she stated using Benadryl cream three times on 9/10, did not use the loratidine and has been using the Benadryl cream once daily since. She stated that the redness and itching have both greatly improved.
Age: 50.0
Sex: M
Vaccine: VARZOS
Symptoms: Rash
Clinical narrative: RASH, ON INSIDE RIGHT THIGH, DISSIPATING BUT STILL PRESENT ON SEP-13-2011
Age: 40.0
Sex: F
Vaccine: FLU3
Symptoms: Chest discomfort, Dyspnoea, Pharyngeal oedema
Clinical narrative: Approximately 1 1/2 hrs. after receiving FLUZONE client began to feel SOB, tightness in her chest, & throat edema. Her symptoms worsened & she went to an Urgent Care clinic. She was given epinephrine, prednisone, ZYRTEC & an inhaler.
Age: 20.0
Sex: F
Vaccine: FLUX, IPV, MEN, YF
Symptoms: Hypersensitivity, Injection site pain, Injection site rash, Pyrexia, Tremor
Clinical narrative: High Fever, 103, shaking, vomiting, large and extremely painful bump at injection site of polio vaccine (also was vaccinated with yellow fever, flu and meningococol at the same time). Diagnosed with allergic reaction.
Age: 20.0
Sex: F
Vaccine: FLUX, IPV, MEN, YF
Symptoms: Vomiting
Clinical narrative: High Fever, 103, shaking, vomiting, large and extremely painful bump at injection site of polio vaccine (also was vaccinated with yellow fever, flu and meningococol at the same time). Diagnosed with allergic reaction.
Age: 3.0
Sex: F
Vaccine: DTAP, MMR
Symptoms: Injection site erythema, Injection site swelling
Clinical narrative: Client showed up to office appt. with reddened, slightly swollen arm where DTAP shot had been given days earlier. Mother was unaware until nurse noticed it.
Age: 11.0
Sex: M
Vaccine: HPV4
Symptoms: Alopecia, Trichorrhexis
Clinical narrative: Excessive hair loss.  Her hair had become very brittle and would break or fall out when washing.  This was 2nd Gardasil shot. She developed pneumonia after 1st shot.
Age: 46.0
Sex: F
Vaccine: FLU3
Symptoms: Chills, Headache, Pain, Pyrexia
Clinical narrative: Headache, fever, chills, body ache
Age: 25.0
Sex: F
Vaccine: SMALL
Symptoms: Blister, Pruritus, Rash maculovesicular, Rash papular, Skin lesion
Clinical narrative: 3 weeks after the vaccine-patient developed a large macular, vesicular, blistering rash around the lesion, and other blisters throughout her body-arms, legs, upper chest, some on back, face, on her ears bilaterally. Most were yellow-fluid filled blisters- she also had erythematous papules throughout her body. +intensely itchy. no other systemic sxs.  She was given Zyrtec and Atarax TID for breakthrough itch. Follow-up with dermatology in am-to evaluate for any superinfection.
Age: 33.0
Sex: M
Vaccine: FLU3
Symptoms: Muscular weakness, Paraesthesia
Clinical narrative: Pt states he has began to feel tingling in his wrist and fingers. He also stated he has weakness in his wrist.
Age: 50.0
Sex: M
Vaccine: FLU3
Symptoms: Headache, Rash, Urticaria
Clinical narrative: Headaches within 3 hours and hives/rash within 8 hours post vaccination
Age: 26.0
Sex: M
Vaccine: PPV
Symptoms: Erythema, Pain of skin, Pyrexia, Skin induration
Clinical narrative: Fevers to 104 starting several hours after vaccine administration, erythematous, painful, indurated skin reaction starting the following day and persisting for several days.
Age: 24.0
Sex: F
Vaccine: FLU3
Symptoms: Headache, Pruritus, Rash
Clinical narrative: headache, itchiness, rash
Age: 72.0
Sex: F
Vaccine: FLU3, PPV
Symptoms: Influenza like illness, Insomnia
Clinical narrative: Flu like symptoms. Unable to sleep.
Age: 83.0
Sex: M
Vaccine: FLU3
Symptoms: Chills, Disorientation, Gait disturbance, Hyperhidrosis, Pyrexia
Clinical narrative: Fever of 101.5 taken with a mercury thermometer under the tongue.  And chills, sweating, difficulty walking, some disorientation.
Age: 75.0
Sex: M
Vaccine: FLU3, PPV
Symptoms: Influenza like illness, Insomnia
Clinical narrative: Flu like symptoms. Unable to sleep.
Age: 68.0
Sex: F
Vaccine: FLUX
Symptoms: Cold sweat, Cough, Fatigue, Headache, Pain
Clinical narrative: vertigo, cold sweat, vomiting, fatigue, low grade temp, body aches, cough, headache-----rest
Age: 68.0
Sex: F
Vaccine: FLUX
Symptoms: Pyrexia, Vertigo, Vomiting
Clinical narrative: vertigo, cold sweat, vomiting, fatigue, low grade temp, body aches, cough, headache-----rest
Age: 0.32
Sex: M
Vaccine: DTAPHEPBIP, HIBV, PNC13, RV1
Symptoms: Abnormal behaviour, Blood culture, Body temperature increased, Diarrhoea, Frequent bowel movements
Clinical narrative: 8/31/2011 9:21:01 AM > seen for WCC and received shots on 8/29.  Mom states that he has been having "runny diarrhea stools" since yest.  Mom states that "stooling about q 2 hrs" - total of 7-8 all day yest, he did spit up yest - which is not normal for him & wasn't his normal "cooing" self . 100.7 (ax w/ degree added) yest.  voiding well.
Age: 0.32
Sex: M
Vaccine: DTAPHEPBIP, HIBV, PNC13, RV1
Symptoms: Full blood count, Infantile spitting up, Metabolic function test, Stool analysis
Clinical narrative: 8/31/2011 9:21:01 AM > seen for WCC and received shots on 8/29.  Mom states that he has been having "runny diarrhea stools" since yest.  Mom states that "stooling about q 2 hrs" - total of 7-8 all day yest, he did spit up yest - which is not normal for him & wasn't his normal "cooing" self . 100.7 (ax w/ degree added) yest.  voiding well.
Age: 0.32
Sex: M
Vaccine: DTAPHEPBIP, HIBV, PNC13, RV1
Symptoms: Blood culture, Full blood count, Metabolic function test, Stool analysis, Unevaluable event
Clinical narrative: the child was born prematurely at 34 weeks gestation via repeat C-section delivery at Lafayette General Medical Center as twin A of a twin gestation. At delivery the child had some respiratory difficulty and required supplemental oxygen and CPAP therapy therefore was admitted to the NICU. The child did have some initial apnea of prematurity however was apnea 3 x 7 days prior to discharge to home. Apgars were 3 and 9.
Age: 0.15
Sex: M
Vaccine: DTAPHEPBIP, HIBV, PNC13, RV1
Symptoms: Body temperature, Culture stool, Diarrhoea, Rotavirus test
Clinical narrative: 9/13/2011 12:22:13 PM > received shots on Friday, 9/9:  was noted to have a small temp over the weekend (99) & has been having diarrhea since; stooling at least 10; medium - large watery stools noted.  Voiding well, no vomiting noted, no blood or mucus noted in stools.  Eating well (BFing - 5 oz q 4 hrs)
Age: 42.0
Sex: F
Vaccine: FLU3
Symptoms: Axillary mass, Injection site pain
Clinical narrative: soreness at injection site; lump the size of a walnut in armpit
Age: 67.0
Sex: M
Vaccine: FLUX
Symptoms: Dizziness, Flushing, Hypotension
Clinical narrative: Pt. became flushed, light headed, and felt like he was going to faint. Blood pressure was measured and was low. Pt. ate a snack, drank some orange juice, had a fan blowing on him, and rested in the pharmacy before leaving.
Age: 13.0
Sex: F
Vaccine: HPV4
Symptoms: Back pain, Depression, Gastrointestinal disorder, Ligament pain, Myalgia
Clinical narrative: Severe muscle and ligament pain. Upper and lower Back, and legs. Stomach/gut problems and depression.
Age: 13.0
Sex: F
Vaccine: HPV4
Symptoms: Pain in extremity
Clinical narrative: Severe muscle and ligament pain. Upper and lower Back, and legs. Stomach/gut problems and depression.
Age: 5.0
Sex: F
Vaccine: DTAP, IPV, MMR
Symptoms: Body temperature increased, Swelling, Tenderness
Clinical narrative: Temp 100.3, swelling, tenderness, treated with Benadryl
Age: 54.0
Sex: M
Vaccine: FLU3
Symptoms: Fatigue, Malaise, Mobility decreased, Musculoskeletal stiffness, Myalgia
Clinical narrative: I experienced deep muscle aches; right side neck muscle very sore and stiff, difficult to move neck; general malaise and fatigue.
Age: 54.0
Sex: M
Vaccine: FLU3
Symptoms: Neck pain
Clinical narrative: I experienced deep muscle aches; right side neck muscle very sore and stiff, difficult to move neck; general malaise and fatigue.
Age: 14.0
Sex: F
Vaccine: FLUN3, HPVX
Symptoms: Chest pain, Oropharyngeal pain, Pain, Pyrexia, Respiratory disorder
Clinical narrative: achy at first, then fever for 5 days of 102, chest pain, sore throat
Age: 5.0
Sex: M
Vaccine: DTAP, IPV
Symptoms: Abdominal pain upper, Injection site erythema, Injection site induration, Injection site urticaria, Lethargy
Clinical narrative: Patient (5yo male) was given DPT booster and polio vaccinations in left arm at same appointment.  Later that day patient complained that stomach hurt and that he didn't feel good.  Was lethargic.  This resolved.  The next day (09/10/2011), patient again complained that he didn't feel good and ramped up to lethargy.  This cleared up after a while.  Later that night (7PM, 09/09/2011) saw that patient had a large 2 inch welt on left arm at site of vaccination.  This was hard and red.  This welt subsided after a couple of days.
Age: 5.0
Sex: M
Vaccine: DTAP, IPV
Symptoms: Malaise
Clinical narrative: Patient (5yo male) was given DPT booster and polio vaccinations in left arm at same appointment.  Later that day patient complained that stomach hurt and that he didn't feel good.  Was lethargic.  This resolved.  The next day (09/10/2011), patient again complained that he didn't feel good and ramped up to lethargy.  This cleared up after a while.  Later that night (7PM, 09/09/2011) saw that patient had a large 2 inch welt on left arm at site of vaccination.  This was hard and red.  This welt subsided after a couple of days.
Age: 23.0
Sex: F
Vaccine: HPV4, HPV4
Symptoms: Acute promyelocytic leukaemia, Anaemia, Night sweats, Pyrexia
Clinical narrative: Diagnosed March 11th with APL. No family history. Injected with first round of HPV vaccine February 14, diagnosed with APL March 11th. Acute onset; no tangible symptoms until roughly 10 days before diagnosis (anemia, fever, night sweats)
Age: 23.0
Sex: F
Vaccine: HPV4, HPV4
Symptoms: Acute promyelocytic leukaemia, Adnexa uteri cyst, Alanine aminotransferase increased, Anaemia, Ascites
Clinical narrative: Diagnosed March 11th with APL. No family history. Injected with first round of HPV vaccine February 14, diagnosed with APL March 11th. Acute onset; no tangible symptoms until roughly 10 days before diagnosis (anemia, fever, night sweats)
Age: 23.0
Sex: F
Vaccine: HPV4, HPV4
Symptoms: Aspartate aminotransferase increased, Aspiration bone marrow normal, Atelectasis, Biopsy bone marrow normal, Blast cells present
Clinical narrative: Diagnosed March 11th with APL. No family history. Injected with first round of HPV vaccine February 14, diagnosed with APL March 11th. Acute onset; no tangible symptoms until roughly 10 days before diagnosis (anemia, fever, night sweats)
Age: 23.0
Sex: F
Vaccine: HPV4, HPV4
Symptoms: Chemotherapy, Computerised tomogram abdomen abnormal, Computerised tomogram thorax abnormal, Disseminated intravascular coagulation, Haematocrit decreased
Clinical narrative: Diagnosed March 11th with APL. No family history. Injected with first round of HPV vaccine February 14, diagnosed with APL March 11th. Acute onset; no tangible symptoms until roughly 10 days before diagnosis (anemia, fever, night sweats)
Age: 23.0
Sex: F
Vaccine: HPV4, HPV4
Symptoms: Haemoglobin decreased, Laboratory test abnormal, Lung consolidation, Lymphocyte percentage increased, Neutrophil percentage decreased
Clinical narrative: Diagnosed March 11th with APL. No family history. Injected with first round of HPV vaccine February 14, diagnosed with APL March 11th. Acute onset; no tangible symptoms until roughly 10 days before diagnosis (anemia, fever, night sweats)
Age: 23.0
Sex: F
Vaccine: HPV4, HPV4
Symptoms: Night sweats, Periportal oedema, Platelet count decreased, Pleural effusion, Pyrexia
Clinical narrative: Diagnosed March 11th with APL. No family history. Injected with first round of HPV vaccine February 14, diagnosed with APL March 11th. Acute onset; no tangible symptoms until roughly 10 days before diagnosis (anemia, fever, night sweats)
Age: 23.0
Sex: F
Vaccine: HPV4, HPV4
Symptoms: White blood cell count decreased
Clinical narrative: Diagnosed March 11th with APL. No family history. Injected with first round of HPV vaccine February 14, diagnosed with APL March 11th. Acute onset; no tangible symptoms until roughly 10 days before diagnosis (anemia, fever, night sweats)
Age: 19.0
Sex: M
Vaccine: FLU3
Symptoms: Injection site rash
Clinical narrative: Rash at site injection site Rt upper arm (plue) and (L) FA.
Age: 61.0
Sex: F
Vaccine: VARZOS
Symptoms: Asthenia, Pain in extremity
Clinical narrative: Patient describes consistent weakness & intermittent pain the arm in which injection was given. Patient says symptoms began within 24 hours of injection & has continued >4 months post-injection. Patient has not sought medical care for symptoms.
Age: 27.0
Sex: F
Vaccine: HEP
Symptoms: Joint swelling, Urticaria
Clinical narrative: Patient broke out in hives. Dose admin on 8/29/11 (Mon) broke out in hives (Wed) 8/31/11 swollen joints, pt took BENADRYL.
Age: 56.0
Sex: F
Vaccine: FLU3
Symptoms: Pain in extremity
Clinical narrative: Pt complained about arm pain and went to her doctor, doctor said the injection may have gotten into the tendon & prescribed anti-inflammatories.
Age: 71.0
Sex: U
Vaccine: FLU3, PPV
Symptoms: Injection site erythema, Injection site pain, Injection site swelling
Clinical narrative: Pt noticed couple hours after being administered pneumonia vaccine that site was swollen, red, and pain. Pt called pharmacy 9-13-11 to report reaction. As of today, no pain no redness, slight edema remains.
Age: 4.0
Sex: F
Vaccine: DTAPIPV, FLU3, HEPA, MMR, VARCEL
Symptoms: Injection site erythema, Injection site pruritus
Clinical narrative: Red itchy at site of vaccine.
Age: 47.0
Sex: F
Vaccine: PPV, TDAP
Symptoms: Injection site erythema, Injection site swelling, Vomiting
Clinical narrative: Pt had redness and swelling at the site of her Tdap vaccine. Pt reported vomiting for 2 days.
Sex: U
Vaccine: FLU3
Symptoms: Emotional distress, Myalgia
Clinical narrative: Received injection 9/11 - woke up next morning in distress, muscle aches/pains - resolved as of 9/13 w/o medical attention.
Age: 44.0
Sex: M
Vaccine: FLU3
Symptoms: Rash, Urticaria
Clinical narrative: Pt had rash & hives on most of body, including arms, legs & torso. Starting using po BENADRYL & hydrocortisone cream.
Age: 68.0
Sex: M
Vaccine: FLU(H1N1)
Symptoms: Brain neoplasm, Death, Diplopia, Dysphagia, Fall
Clinical narrative: Shortly after the vaccine, he started feeling tired, out of sorts, disconnected. In January 2010, he started having headaches, seeing double, difficulty swallowing, eventually lost continence. Would fall and be unable to get up. MRI on 1-29-10 dx 2cm tumor in ponds. Admitted to hospital. Died 2-14-10.
Age: 68.0
Sex: M
Vaccine: FLU(H1N1)
Symptoms: Fatigue, Feeling abnormal, Headache, Incontinence, Nuclear magnetic resonance imaging brain abnormal
Clinical narrative: Shortly after the vaccine, he started feeling tired, out of sorts, disconnected. In January 2010, he started having headaches, seeing double, difficulty swallowing, eventually lost continence. Would fall and be unable to get up. MRI on 1-29-10 dx 2cm tumor in ponds. Admitted to hospital. Died 2-14-10.
Age: 11.0
Sex: F
Vaccine: MNQ, MNQ
Symptoms: Pruritus, Rash macular
Clinical narrative: Pt called 9-14-11 to report of red itchy splotches in face area. Denied SOB, or trouble breathing or swelling in throat, nose area. Mom said gave BENADRYL last night & it seemed to help.
Age: 11.0
Sex: F
Vaccine: MNQ, MNQ
Symptoms: Erythema, Pruritus, Rash macular
Clinical narrative: Pt called 9-14-11 to report of red itchy splotches in face area. Denied SOB, or trouble breathing or swelling in throat, nose area. Mom said gave BENADRYL last night & it seemed to help.
Age: 18.0
Sex: F
Vaccine: HPV4, MNQ
Symptoms: Skin discolouration, Syncope
Clinical narrative: 9/9/11 1700 patient fainted, laid patient down on exam table. Responded in 30 sec, then had 2nd episode of syncope which lasted about 45 sec, pt required O2 BP 80/60 P 51, BP 80/60 P 51 gave patient glucose tablet, and water 1723 BP 82/50 P 51 at 1745 BP 97/66 color returned, feeling better 1800 O2 D/C. Left clinic with boyfriend he drove her home.
Sex: F
Vaccine: DTAP, FLUN3, IPV, MMRV
Symptoms: Injection site erythema, Injection site swelling
Clinical narrative: Redness and swelling in the left thigh.
Age: 13.0
Sex: F
Vaccine: FLU3, HPV4
Symptoms: Dyspnoea, Oedema mouth, Urticaria
Clinical narrative: Flu & GARDASIL vaccine given about 16:10, on the way home (20 min) pt developed oral swelling and breathing difficulty, urticarial rash - went to Urgent Care, then to Emergency Dept.
Age: 88.0
Sex: F
Vaccine: VARZOS
Symptoms: Dyspnoea, Lip swelling, Swelling face
Clinical narrative: This is in follow-up to report(s) previously submitted on 9/2/2011. Information has been received from an office manager and an office worker concerning an 88 year old female patient, who on 23-AUG-2011, was vaccinated with a one time dose of ZOSTAVAX (Merck) (Lot # 671017/0751AA, Exp. Date: 12-AUG-2012) 0.65 ml, subcutaneously. The office manager and office worker reported that on 23-AUG-2011, the patient experienced shortness of breath, swelling of the face and lips and the patient was hospitalized on the same date. It was unspecified if the patient received any treatment for the events. At the time of the report, patient's outcome was unknown. Follow up information has been received concerning an 88 year old female with anxiety and cardiac failure congestive and no illness at the time of vaccination, who on 24-AUG-2011 recovered from shortness of breath, swelling of the face and swelling of lips. No further information is available.
Age: 82.0
Sex: U
Vaccine: FLU3
Symptoms: Headache, Pyrexia, Throat irritation
Clinical narrative: Low grade fever, scratchy throat, headache left side.
Age: 19.0
Sex: F
Vaccine: HPV4, TDAP, VARCEL, HPV4, TDAP, VARCEL, HPV4, TDAP, VARCEL
Symptoms: Drug exposure before pregnancy, Pregnancy test urine negative
Clinical narrative: Information has been received from a nurse, for VARIVAX (Merck) and GARDASIL, both Pregnancy Registry products, concerning a 19 year old female with drug allergies to erythromycin, codeine, CECLOR and ampicillin and a history of kidney stones who on 04-NOV-2010 was vaccinated subcutaneously with 0.5 ml VARIVAX (Merck) (lot # 666850/0714Z, expiration date 14-MAR-2012) in left arm and a 0.5 ml dose of GARDASIL (lot # 666121/1778Y, expiration date 19-AUG-2012) intramuscularly in the right arm. On the same day the patient was also vaccinated with ADACEL. Concomitant therapy also included ORTHO TRI-CYCLEN LO birth control pills. Prior to getting vaccines, the patient was given a urine pregnancy test in the health center on 04-NOV-2010 which was negative. On 23-NOV-2010 the patient came into the health center stating she felt like she was pregnant. Urine pregnancy test was positive. Her last menstrual period (LMP) was on 15-OCT-2010, and estimated delivery date (EDD) was on 22-JUL-2011. The patient was not experiencing any problems. No adverse effect reported. Follow-up information has been received from the nurse via a Initial Pregnancy Questionnaire, for VARIVAX (Merck) and GARDASIL, both Pregnancy Registry products, concerning the 19 year old female with no illness at time of vaccination, who on 04-NOV-2010 was vaccinated with the third 0.5 ml dose of VARIVAX (Merck) (lot # 666850/0714Z, expiration date 14-MAR-2012) subcutaneously in left arm. Other suspect therapy included the second 0.5 ml dose of GARDASIL (lot # 666121/1778Y, expiration date 19-AUG-2012) intramuscularly in right deltoid on the same day. Concomitant therapy included the second dose of ADACEL (lot# 3281B/A) intramuscularly in left deltoid on the same day. The patient did not test for varicella antibodies before vaccination with varicella-zoster virus (VZV) contained vaccine. No adverse effect reported. Follow-up information has been received from the nurse via an Outcome Pregnancy Questionnaire, for VARIVAX (Merck) and GARDASIL, both Pregnancy Registry products, concerning the patient who delivered a normal male baby on 09-AUG-2011 via C-section since the baby had low heart rate. The neonate weighed 8 lbs. 5 oz. at 42 weeks gestation. There were no congenital anomalies. The baby had respiratory problem and fluid on lung, and was in Intensive Care Unit (ICU) from 09-AUG-2011 to 12-AUG-2011. It was reported that there was no complication or infections or illness during pregnancy and no concurrent medical conditions. There was no other medication used during this pregnancy. Upon internal review, the C-section - baby had low heart rate was determined to be an other important medical event. The baby's experience has been captured in WAES 1011USA03447B1. No further information is available.
Age: 19.0
Sex: F
Vaccine: HPV4, TDAP, VARCEL, HPV4, TDAP, VARCEL, HPV4, TDAP, VARCEL
Symptoms: Caesarean section, Foetal disorder, Human chorionic gonadotropin positive, Maternal exposure during pregnancy
Clinical narrative: Information has been received from a nurse, for VARIVAX (Merck) and GARDASIL, both Pregnancy Registry products, concerning a 19 year old female with drug allergies to erythromycin, codeine, CECLOR and ampicillin and a history of kidney stones who on 04-NOV-2010 was vaccinated subcutaneously with 0.5 ml VARIVAX (Merck) (lot # 666850/0714Z, expiration date 14-MAR-2012) in left arm and a 0.5 ml dose of GARDASIL (lot # 666121/1778Y, expiration date 19-AUG-2012) intramuscularly in the right arm. On the same day the patient was also vaccinated with ADACEL. Concomitant therapy also included ORTHO TRI-CYCLEN LO birth control pills. Prior to getting vaccines, the patient was given a urine pregnancy test in the health center on 04-NOV-2010 which was negative. On 23-NOV-2010 the patient came into the health center stating she felt like she was pregnant. Urine pregnancy test was positive. Her last menstrual period (LMP) was on 15-OCT-2010, and estimated delivery date (EDD) was on 22-JUL-2011. The patient was not experiencing any problems. No adverse effect reported. Follow-up information has been received from the nurse via a Initial Pregnancy Questionnaire, for VARIVAX (Merck) and GARDASIL, both Pregnancy Registry products, concerning the 19 year old female with no illness at time of vaccination, who on 04-NOV-2010 was vaccinated with the third 0.5 ml dose of VARIVAX (Merck) (lot # 666850/0714Z, expiration date 14-MAR-2012) subcutaneously in left arm. Other suspect therapy included the second 0.5 ml dose of GARDASIL (lot # 666121/1778Y, expiration date 19-AUG-2012) intramuscularly in right deltoid on the same day. Concomitant therapy included the second dose of ADACEL (lot# 3281B/A) intramuscularly in left deltoid on the same day. The patient did not test for varicella antibodies before vaccination with varicella-zoster virus (VZV) contained vaccine. No adverse effect reported. Follow-up information has been received from the nurse via an Outcome Pregnancy Questionnaire, for VARIVAX (Merck) and GARDASIL, both Pregnancy Registry products, concerning the patient who delivered a normal male baby on 09-AUG-2011 via C-section since the baby had low heart rate. The neonate weighed 8 lbs. 5 oz. at 42 weeks gestation. There were no congenital anomalies. The baby had respiratory problem and fluid on lung, and was in Intensive Care Unit (ICU) from 09-AUG-2011 to 12-AUG-2011. It was reported that there was no complication or infections or illness during pregnancy and no concurrent medical conditions. There was no other medication used during this pregnancy. Upon internal review, the C-section - baby had low heart rate was determined to be an other important medical event. The baby's experience has been captured in WAES 1011USA03447B1. No further information is available.
Age: 19.0
Sex: F
Vaccine: HPV4, TDAP, VARCEL, HPV4, TDAP, VARCEL, HPV4, TDAP, VARCEL
Symptoms: Caesarean section, Foetal disorder, Maternal exposure during pregnancy, Neonatal disorder
Clinical narrative: Information has been received from a nurse, for VARIVAX (Merck) and GARDASIL, both Pregnancy Registry products, concerning a 19 year old female with drug allergies to erythromycin, codeine, CECLOR and ampicillin and a history of kidney stones who on 04-NOV-2010 was vaccinated subcutaneously with 0.5 ml VARIVAX (Merck) (lot # 666850/0714Z, expiration date 14-MAR-2012) in left arm and a 0.5 ml dose of GARDASIL (lot # 666121/1778Y, expiration date 19-AUG-2012) intramuscularly in the right arm. On the same day the patient was also vaccinated with ADACEL. Concomitant therapy also included ORTHO TRI-CYCLEN LO birth control pills. Prior to getting vaccines, the patient was given a urine pregnancy test in the health center on 04-NOV-2010 which was negative. On 23-NOV-2010 the patient came into the health center stating she felt like she was pregnant. Urine pregnancy test was positive. Her last menstrual period (LMP) was on 15-OCT-2010, and estimated delivery date (EDD) was on 22-JUL-2011. The patient was not experiencing any problems. No adverse effect reported. Follow-up information has been received from the nurse via a Initial Pregnancy Questionnaire, for VARIVAX (Merck) and GARDASIL, both Pregnancy Registry products, concerning the 19 year old female with no illness at time of vaccination, who on 04-NOV-2010 was vaccinated with the third 0.5 ml dose of VARIVAX (Merck) (lot # 666850/0714Z, expiration date 14-MAR-2012) subcutaneously in left arm. Other suspect therapy included the second 0.5 ml dose of GARDASIL (lot # 666121/1778Y, expiration date 19-AUG-2012) intramuscularly in right deltoid on the same day. Concomitant therapy included the second dose of ADACEL (lot# 3281B/A) intramuscularly in left deltoid on the same day. The patient did not test for varicella antibodies before vaccination with varicella-zoster virus (VZV) contained vaccine. No adverse effect reported. Follow-up information has been received from the nurse via an Outcome Pregnancy Questionnaire, for VARIVAX (Merck) and GARDASIL, both Pregnancy Registry products, concerning the patient who delivered a normal male baby on 09-AUG-2011 via C-section since the baby had low heart rate. The neonate weighed 8 lbs. 5 oz. at 42 weeks gestation. There were no congenital anomalies. The baby had respiratory problem and fluid on lung, and was in Intensive Care Unit (ICU) from 09-AUG-2011 to 12-AUG-2011. It was reported that there was no complication or infections or illness during pregnancy and no concurrent medical conditions. There was no other medication used during this pregnancy. Upon internal review, the C-section - baby had low heart rate was determined to be an other important medical event. The baby's experience has been captured in WAES 1011USA03447B1. No further information is available.
Age: 53.0
Sex: M
Vaccine: FLU3, FLU3
Symptoms: Myelitis transverse
Clinical narrative: Initial report received from a researcher who is a consumer or other non-health care professional; and from a search of the VAERS database on 06 September 2011 (VAERS ID number 418503). A 53 year-old male patient (date of birth not reported) with concurrent illness of left lower lobe pneumonia, and pre-existing conditions of diabetes, hypertension, hyperlipidemia, and excessive obesity, had received a first 0.5 mL intramuscular left deltoid injection of FLUZONE SV 2009-2010 (lot number reported as U351AA, which is not a valid sanofi pasteur lot number; the only lot number available for FLUZONE SV 2009-2010 at the time was U3351AA) on 30 November 2009 (also reported as 20 November 2009) and 2 days later experienced transverse myelitis temporally related to the flu shot. The patient was hospitalized 2 days after that for an extended stay of 19 days (approximate discharge date 22 December 2009) with symptoms that had developed over 3 days prior. The patient was reported as being unable to walk and disability was reported. The patient has not recovered. Concomitant medications included: Insulin, Metformin, antacid (unspecified), and VYTORIN. Documents held by sender: None.
Age: 53.0
Sex: M
Vaccine: FLU3, FLU3
Symptoms: Abasia, Disability, Myelitis transverse
Clinical narrative: Initial report received from a researcher who is a consumer or other non-health care professional; and from a search of the VAERS database on 06 September 2011 (VAERS ID number 418503). A 53 year-old male patient (date of birth not reported) with concurrent illness of left lower lobe pneumonia, and pre-existing conditions of diabetes, hypertension, hyperlipidemia, and excessive obesity, had received a first 0.5 mL intramuscular left deltoid injection of FLUZONE SV 2009-2010 (lot number reported as U351AA, which is not a valid sanofi pasteur lot number; the only lot number available for FLUZONE SV 2009-2010 at the time was U3351AA) on 30 November 2009 (also reported as 20 November 2009) and 2 days later experienced transverse myelitis temporally related to the flu shot. The patient was hospitalized 2 days after that for an extended stay of 19 days (approximate discharge date 22 December 2009) with symptoms that had developed over 3 days prior. The patient was reported as being unable to walk and disability was reported. The patient has not recovered. Concomitant medications included: Insulin, Metformin, antacid (unspecified), and VYTORIN. Documents held by sender: None.
Age: 44.0
Sex: F
Vaccine: FLU3, FLUX
Symptoms: Injected limb mobility decreased, Musculoskeletal pain, Paraesthesia
Clinical narrative: Immediate pain and burning sensation.  Loss range of motion during first 24 hours and continued to get worse.  Tingling and numbing sensations down arm and hands.  Went to doctor.  Prescribed Prednisone 4MG Dospak 21's.  Range of motion back 90% but still constant pain, numbness, tingling.  Pain in head, neck, shoulder, arm and hand.  Shoulder gets "stuck" in position and hard to get "unstuck".
Age: 44.0
Sex: F
Vaccine: FLU3, FLUX
Symptoms: Burning sensation, Headache, Hypoaesthesia, Immediate post-injection reaction, Joint dislocation
Clinical narrative: Immediate pain and burning sensation.  Loss range of motion during first 24 hours and continued to get worse.  Tingling and numbing sensations down arm and hands.  Went to doctor.  Prescribed Prednisone 4MG Dospak 21's.  Range of motion back 90% but still constant pain, numbness, tingling.  Pain in head, neck, shoulder, arm and hand.  Shoulder gets "stuck" in position and hard to get "unstuck".
Age: 44.0
Sex: F
Vaccine: FLU3, FLUX
Symptoms: Joint range of motion decreased, Musculoskeletal pain, Neck pain, Pain, Pain in extremity
Clinical narrative: Immediate pain and burning sensation.  Loss range of motion during first 24 hours and continued to get worse.  Tingling and numbing sensations down arm and hands.  Went to doctor.  Prescribed Prednisone 4MG Dospak 21's.  Range of motion back 90% but still constant pain, numbness, tingling.  Pain in head, neck, shoulder, arm and hand.  Shoulder gets "stuck" in position and hard to get "unstuck".
Age: 44.0
Sex: F
Vaccine: FLU3, FLUX
Symptoms: Paraesthesia
Clinical narrative: Immediate pain and burning sensation.  Loss range of motion during first 24 hours and continued to get worse.  Tingling and numbing sensations down arm and hands.  Went to doctor.  Prescribed Prednisone 4MG Dospak 21's.  Range of motion back 90% but still constant pain, numbness, tingling.  Pain in head, neck, shoulder, arm and hand.  Shoulder gets "stuck" in position and hard to get "unstuck".
Age: 20.0
Sex: F
Vaccine: HPV4
Symptoms: Convulsion, Derealisation, Dizziness, Dizziness postural, Fall
Clinical narrative: Immediatly after I had the shot, I started to see spots in my eyes and as I was walking out of the doctor's office I felt faint and lost consciousness and fell into a wall. I woke up a few minutes later with several doctors and nurses standing around me they told me that I had fainted and began to convulse. I was brought to a recovery area of the clinic but it was decided it was best if I go to the hospital because of the pain in my head and neck. Life has not been the same since then I have moments of feeling dizzy especially upon standing, permanent derealization, and floaters in my eyes.
Age: 20.0
Sex: F
Vaccine: HPV4
Symptoms: Headache, Immediate post-injection reaction, Loss of consciousness, Neck pain, Syncope
Clinical narrative: Immediatly after I had the shot, I started to see spots in my eyes and as I was walking out of the doctor's office I felt faint and lost consciousness and fell into a wall. I woke up a few minutes later with several doctors and nurses standing around me they told me that I had fainted and began to convulse. I was brought to a recovery area of the clinic but it was decided it was best if I go to the hospital because of the pain in my head and neck. Life has not been the same since then I have moments of feeling dizzy especially upon standing, permanent derealization, and floaters in my eyes.
Age: 20.0
Sex: F
Vaccine: HPV4
Symptoms: Visual impairment, Vitreous floaters
Clinical narrative: Immediatly after I had the shot, I started to see spots in my eyes and as I was walking out of the doctor's office I felt faint and lost consciousness and fell into a wall. I woke up a few minutes later with several doctors and nurses standing around me they told me that I had fainted and began to convulse. I was brought to a recovery area of the clinic but it was decided it was best if I go to the hospital because of the pain in my head and neck. Life has not been the same since then I have moments of feeling dizzy especially upon standing, permanent derealization, and floaters in my eyes.
Age: 27.0
Sex: M
Vaccine: SMALL
Symptoms: Rash papular
Clinical narrative: Patient reported to facility with multiple scattered papules on all surfaces of skin, excluding the palms. Patient showed no ecchymosis.
Age: 13.0
Sex: M
Vaccine: FLU3, PPV
Symptoms: Chills, Injection site swelling, Musculoskeletal stiffness, Pain in extremity, Pyrexia
Clinical narrative: 9-9-11 started with arm soreness, & fever (101.2) - then 9-10-11 temp increased to 104 degrees, chills, on call Dr. sent to ER for evaluation - pt had had large swelling at site of vaccine. Admitted to hospital - put on IV antibiotics - having some arm pain/stiffness. Was diagnosed with adverse reaction to PNEUMOVAX 23.
Age: 13.0
Sex: M
Vaccine: FLU3, PPV
Symptoms: Red blood cell sedimentation rate increased, Vaccination complication, White blood cell count increased
Clinical narrative: 9-9-11 started with arm soreness, & fever (101.2) - then 9-10-11 temp increased to 104 degrees, chills, on call Dr. sent to ER for evaluation - pt had had large swelling at site of vaccine. Admitted to hospital - put on IV antibiotics - having some arm pain/stiffness. Was diagnosed with adverse reaction to PNEUMOVAX 23.
Age: 20.0
Sex: F
Vaccine: HPV4
Symptoms: Abortion induced, Maternal exposure during pregnancy, Smear cervix abnormal
Clinical narrative: Information has been received from a physician for the pregnancy Registry for GARDASIL concerning a 20 year old female patient with no known drug allergies and with bartholin's cyst, low grade dysplasia who on 19-JUL-2011, was vaccinated with the first dose of GARDASIL (route and dose not reported) (Lot number 099Z is an invalid lot number for GARDASIL Exp: 14-OCT-2012). There was no concomitant medication. The patient was pregnant, at this same office visit a follow up papanicolaou test (PAP) was performed (results not provided). In February 2011 papanicolaou test was taken which was abnormal. The patient sought medical attention by called to the office. At the time of vaccination, the physician stated client verbalized that her LMP was 12-JUL-2011, but now told physician her LMP might had been in June 2011. EDD: 07-MAR-2012. The physician stated she prescribed antibiotics for the patient's cyst, but the patient did not take them. The physician stated that the patient had not experienced any adverse effects. Follow-up information has been received via outcome pregnancy questionnaire from a health care professional who reported that on an unspecified date the patient experienced an elective termination of pregnancy. At the time of the report, the patient's outcome from elective termination of pregnancy was unknown. Upon internal review, elective termination of pregnancy was considered to be an other important medical event. Additional information has been requested.
Age: 66.0
Sex: M
Vaccine: PPV
Symptoms: Inflammation, Injection site inflammation, Local reaction, Rash
Clinical narrative: Rash & local inflammatory reaction around injection site. Ibuprofen 800 mg TID.
Age: 78.0
Sex: F
Vaccine: FLU3
Symptoms: Abasia, Guillain-Barre syndrome, Hypoaesthesia, Neuropathy peripheral, Paraesthesia
Clinical narrative: Received flu shot 10/16/10. Late November 2010 sudden onset of numbness and tingling to point where she could not walk. Admitted to hospital. Still has numbness in her finger tips b/l and left forearm and left leg.
Age: 78.0
Sex: F
Vaccine: FLU3
Symptoms: Viral infection
Clinical narrative: Received flu shot 10/16/10. Late November 2010 sudden onset of numbness and tingling to point where she could not walk. Admitted to hospital. Still has numbness in her finger tips b/l and left forearm and left leg.
Age: 7.0
Sex: F
Vaccine: MMR, TD
Symptoms: Pain, Swelling
Clinical narrative: Pain and swelling.
Sex: F
Vaccine: MNQ
Symptoms: Chills, Diarrhoea, Headache, Injection site reaction, Nausea
Clinical narrative: Initial report received from a physician on 02 September 2011. A female patient experienced an "enormous site reaction" one day after receiving an injection of MENACTRA (lot not reported) on 30 August 2011. On 31 August 2011, she was hospitalized with an enormous site reaction, fever, chills, headache, nausea, and diarrhea. The patient had not recovered at the time of the report. No additional information was reported. Of note, the patient also had a site reaction after previous vaccination with Td.
Sex: F
Vaccine: MNQ
Symptoms: Pyrexia
Clinical narrative: Initial report received from a physician on 02 September 2011. A female patient experienced an "enormous site reaction" one day after receiving an injection of MENACTRA (lot not reported) on 30 August 2011. On 31 August 2011, she was hospitalized with an enormous site reaction, fever, chills, headache, nausea, and diarrhea. The patient had not recovered at the time of the report. No additional information was reported. Of note, the patient also had a site reaction after previous vaccination with Td.
Age: 20.0
Sex: F
Vaccine: TDAP
Symptoms: Headache, Hyperhidrosis, Nausea, Pain in extremity, Tenderness
Clinical narrative: Left Arm pain and tenderness radiating to neck accompanied by headache, sweats, nausea for 3 days
Age: 2.0
Sex: M
Vaccine: FLUN3
Symptoms: Rash, Rash generalised
Clinical narrative: Rash on face and body.
Age: 68.0
Sex: F
Vaccine: FLU3
Symptoms: Chills, Malaise, Tremor
Clinical narrative: Patient started experiencing the shakes and chills and felt extremely unwell
Age: 66.0
Sex: M
Vaccine: FLU3
Symptoms: Chills, Eye discharge, Flushing, Lacrimation increased, Lethargy
Clinical narrative: Reported muscle aches; chills, lump in throat; watering & excess mucous formation in eyes; lethargy; blisters in mouth; face flushing; did not take temp.
Age: 66.0
Sex: M
Vaccine: FLU3
Symptoms: Myalgia, Oropharyngeal blistering, Sensation of foreign body
Clinical narrative: Reported muscle aches; chills, lump in throat; watering & excess mucous formation in eyes; lethargy; blisters in mouth; face flushing; did not take temp.